DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF. PREEMPT 2 Chronic Migraine Study Group..
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Cephalalgia 2010;
30: 804-14.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.